Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 3Phase 1/2 2Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 85Lymphoma, Follicular 18Recurrence 11Lymphoma, Large B-Cell, Diffuse 11Neoplasms, Plasma Cell 8Lymphoma 7Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Non-Hodgkin 5Neoplasms 4Lymphoma, Mantle-Cell 4Hematologic Diseases 4Smoldering Multiple Myeloma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Disease Progression 3Paraproteinemias 2Myelodysplastic Syndromes 2Disease 2Anemia 2Sezary Syndrome 1Prostatic Neoplasms 1Polycythemia Vera 1Plasmacytoma 1Neoplasm Metastasis 1Mycosis Fungoides 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1

Interventions

liposomal amphotericin B 2Vorinostat 2Peripheral Blood Stem Cell Transplantation 2Levofloxacin 2Early Intervention, Educational 2Darbepoetin alfa 2zanolimumab 1mogamulizumab 1ferrous sulfate 1ferric gluconate 1Valacyclovir 1Ultraviolet Therapy 1Sucrose 1Radiotherapy 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Ondansetron 1Moxifloxacin 1Morphine 1Methoxsalen 1Lenalidomide 1Ketamine 1Itraconazole 1Fluconazole 1Filgrastim 1Fentanyl 1Epoetin Alfa 1Dextromethorphan 1Cyclophosphamide 1Ciprofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sezary Syndrome × Lenalidomide × Clear all
NCT01098656 2018-07-09

Lenalidomide Maintenance Post-debulking in Advanced CTCL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
21 enrolled
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡